Azodi M

No ORCID on file · 12 papers in corpus · active 2010-2020

Study types

  • article 1
  • case-report 1

Condition tags

  • endometriosis 2
2020
Gynecologic Oncology ·doi:10.1016/j.ygyno.2020.06.484

ObjectiveWhole-exome-sequencing (WES) studies reported c-MYC gene-amplification and HUWE1 gene deletion/mutations in a significant number of cervical-cancer-patients (CC) suggesting HUWE1/c-MYC pathway as potential therapeutic target. We in…

2019
JSLS : Journal of the Society of Laparoendoscopic Surgeons ·doi:10.4293/jsls.2019.00006

Background and objectivesIn this case series, we propose a novel approach to combined vaginal and laparoscopic surgery in which a posterior colpotomy and 2 5-mm abdominal incisions are used to perform benign gynecological procedures. We see…

2018
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.03.050

IntroductionSince the majority of patients are diagnosed at an advanced stage, ovarian cancer remains the most lethal gynecologic malignancy. There is no single biomarker with the sensitivity and specificity required for effective cancer sc…

2018
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-18-0864

Purpose: Uterine serous carcinoma (USC) is a rare and aggressive variant of endometrial cancer. Whole-exome sequencing (WES) studies have recently reported c-Myc gene amplification in a large number of USCs, suggesting c-Myc as a potential …

2015
JSLS : Journal of the Society of Laparoendoscopic Surgeons ·doi:10.4293/jsls.2014.00222

IntroductionPosterior colpotomy incision for specimen retrieval is infrequently used in gynecologic laparoscopic surgery unless a concomitant hysterectomy is performed. We aim to describe a simple and unique technique for creating the colpo…

case-report 2015
Gynecologic oncology ·doi:10.1016/j.ygyno.2015.03.014
article 2015
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2015.08.461
2014
Cancer prevention research (Philadelphia, Pa.) ·doi:10.1158/1940-6207.capr-13-0408

We hypothesized that (i) preclinical biologic evidence exists for the role of androgens in ovarian cancer development and (ii) flutamide treatment of women at high risk for ovarian cancer may identify meaningful tissue biomarkers of androge…

2013
JSLS : Journal of the Society of Laparoendoscopic Surgeons ·doi:10.4293/108680812x13517013317996

Background and objectivesDuring the past few decades, there has been a significant increase in the number of cesarean deliveries, and thus an increase in the number of complications. A common complication of multiple cesarean deliveries is …

2013
JSLS : Journal of the Society of Laparoendoscopic Surgeons ·doi:10.4293/108680813x13693422521755

Background and objectivesWe sought to examine the outcomes of patients with myomatous uteri weighing >1000 g who underwent hysterectomy by one of two modalities, either with a robotic system or by laparotomy.MethodsAll patients who underwen…

2011
Clinical & experimental metastasis ·doi:10.1007/s10585-011-9401-0

We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease. We studied the expres…

2010
British journal of cancer ·doi:10.1038/sj.bjc.6605760

BackgroundUterine serous papillary adenocarcinoma (USPC) is a highly aggressive variant of endometrial cancer. Human immuno-conjugate molecule (hI-con1) is an antibody-like molecule targeted against tissue factor (TF), composed of two human…